Idiopathic Pulmonary Fibrosis

被引：1175
作者：
Lederer, David J. [1 ,2 ]
Martinez, Fernando J. [3 ]
机构：
[1] Columbia Univ, Dept Med, Irving Med Ctr, New York, NY USA
[2] Columbia Univ, Dept Epidemiol, Irving Med Ctr, New York, NY USA
[3] Weill Cornell Med Ctr, Dept Med, New York, NY 10021 USA
来源：
NEW ENGLAND JOURNAL OF MEDICINE | 2018年 / 378卷 / 19期
关键词：
INTERSTITIAL LUNG-DISEASE; MUC5B PROMOTER POLYMORPHISM; GASTROESOPHAGEAL-REFLUX; CLINICAL-PRACTICE; N-ACETYLCYSTEINE; DIAGNOSTIC YIELD; PIRFENIDONE; NINTEDANIB; PREVALENCE; CRYOBIOPSY;
D O I：
10.1056/NEJMra1705751
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
[No abstract available]
引用
收藏
页码：1811 / 1823
页数：13
相关论文
共 100 条
  • [1] P2X3 receptor antagonist (AF-219) in refractory chronic cough: a randomised, double-blind, placebo-controlled phase 2 study
    Abdulqawi, Rayid
    Dockry, Rachel
    Holt, Kimberley
    Layton, Gary
    McCarthy, Bruce G.
    Ford, Anthony P.
    Smith, Jaclyn A.
    [J]. LANCET, 2015, 385 (9974) : 1198 - 1205
  • [2] Efficacy of pirfenidone in patients with idiopathic pulmonary fibrosis with more preserved lung function
    Albera, Carlo
    Costabel, Ulrich
    Fagan, Elizabeth A.
    Glassberg, Marilyn K.
    Gorina, Eduard
    Lancaster, Lisa
    Lederer, David J.
    Nathan, Steven D.
    Spirig, Dominique
    Swigris, Jeff J.
    [J]. EUROPEAN RESPIRATORY JOURNAL, 2016, 48 (03) : 843 - 851
  • [3] Short telomeres are a risk factor for idiopathic pulmonary fibrosis
    Alder, Jonathan K.
    Chen, Julian J. -L.
    Lancaster, Lisa
    Danoff, Sonye
    Su, Shu-Chih
    Cogan, Joy D.
    Vulto, Irma
    Xie, Mingyi
    Qi, Xiaodong
    Tuder, Rubin M.
    Phillips, John A., III
    Lansdorp, Peter M.
    Loyd, James E.
    Armanios, Mary Y.
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2008, 105 (35) : 13051 - 13056
  • [4] Allen RJ, 2017, LANCET RESP MED, V5, P869, DOI [10.1016/s2213-2600(17)30387-9, 10.1016/S2213-2600(17)30387-9]
  • [5] [Anonymous], 2014, NEW ENGL J MED, V370, P2093
  • [6] Telomerase mutations in families with idiopathic pulmonary fibrosis
    Armanios, Mary Y.
    Chen, Julian J. -L.
    Cogan, Joy D.
    Alder, Jonathan K.
    Ingersoll, Roxann G.
    Markin, Cheryl
    Lawson, William E.
    Xie, Mingyi
    Vulto, Irma
    Phillips, John A., III
    Lansdorp, Peter M.
    Greider, Carol W.
    Loyd, James E.
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2007, 356 (13) : 1317 - 1326
  • [7] Occupational and environmental risk factors for idiopathic pulmonary fibrosis: A multicenter case-control study
    Baumgartner, KB
    Samet, JM
    Coultas, DB
    Stidley, CA
    Hunt, WC
    Colby, TV
    Waldron, JA
    [J]. AMERICAN JOURNAL OF EPIDEMIOLOGY, 2000, 152 (04) : 307 - 315
  • [8] A novel formulation of inhaled sodium cromoglicate (PA101) in idiopathic pulmonary fibrosis and chronic cough: a randomised, double-blind, proof-of-concept, phase 2 trial
    Birring, Surinder S.
    Wijsenbeek, Marlies S.
    Agrawal, Sanjay
    van den Berg, Jan W. K.
    Stone, Helen
    Maher, Toby M.
    Tutuncu, Ahmet
    Morice, Alyn H.
    [J]. LANCET RESPIRATORY MEDICINE, 2017, 5 (10) : 806 - 815
  • [9] The use of pretest probability increases the value of high-resolution CT in diagnosing usual interstitial pneumonia
    Brownell, Robert
    Moua, Teng
    Henry, Travis S.
    Elicker, Brett M.
    White, Darin
    Vittinghoff, Eric
    Jones, Kirk D.
    Urisman, Anatoly
    Aravena, Carlos
    Johannson, Kerri A.
    Golden, Jeffrey A.
    King, Talmadge E., Jr.
    Wolters, Paul J.
    Collard, Harold R.
    Ley, Brett
    [J]. THORAX, 2017, 72 (05) : 424 - 429
  • [10] Drug Treatment of Idiopathic Pulmonary Fibrosis Systematic Review and Network Meta-Analysis
    Canestaro, William J.
    Forrester, Sara H.
    Raghu, Ganesh
    Ho, Lawrence
    Devine, Beth E.
    [J]. CHEST, 2016, 149 (03) : 756 - 766
12345678910